Technical Intelligence & Insights
Dive into our comprehensive technical reports covering the Fine Chemical Intermediates sector. We analyze novel patents, catalytic processes, and cost-reduction strategies to streamline your commercial manufacturing.
Discover the novel Cu-catalyzed synthesis of trifluoromethyl-substituted dihydrofuran amines. A robust method for high-purity pharmaceutical intermediates with scalable potential.
Patent CN115353511A details a safe, one-pot synthesis of carbonyl-bridged biheterocycles using in-situ CO generation, offering reliable pharmaceutical intermediate supply.
Patent CN112480015B details a safe one-pot synthesis of 2-trifluoromethyl quinazolinones using nitro compounds, offering significant cost reduction and supply chain reliability for API manufacturing.
Patent CN102964271B details a novel one-step Pd-catalyzed synthesis of 2-cyano-4'-methylbiphenyl, offering significant cost reduction and scalability for sartan drug manufacturers.
Novel metal-free synthesis of trifluoromethyl 1,2,4-triazines via [3+3] cycloaddition. Offers cost reduction in API manufacturing and scalable production capabilities.
Patent CN116621792B enables efficient, water-based synthesis of N-butyl-benzisothiazolinone oxide with high yield, offering sustainable cost reduction and scalable supply for pharmaceutical intermediates.
Novel four-component one-step synthesis enables high-yield, scalable production of structurally diverse calixarene derivatives with superior recognition properties for industrial applications.
Novel ruthenium-catalyzed asymmetric cyclopropanation achieves high enantioselectivity trans-D-chrysanthemic acid with simplified process flow ensuring reliable supply chain efficiency for agrochemical manufacturers.
Patent CN110452150B enables one-step synthesis of axial chiral indole-naphthalene compounds under mild conditions with high optical purity, offering significant cost reduction and reliable supply for pharmaceutical catalysis applications.
Novel axial chiral phosphine-ene ligand enables mild-condition asymmetric allylation with high yield and enantioselectivity, ensuring reliable supply chain for pharmaceutical intermediates.
Patent CN116768812A introduces a novel catalytic method for multi-substituted dihydrooxazoles with high yield and simplified process flow enabling significant cost reduction and enhanced supply chain reliability for flavor and agrochemical applications.
Patent CN107935878A enables atom-economical primary amide synthesis from olefins CO and ammonia This one-pot method ensures high yield stable catalyst performance reducing manufacturing costs enhancing supply chain reliability for pharmaceutical intermediates
Patent CN115286578B introduces a room temperature synthesis method for trifluoromethyl pyrazole intermediates without metal catalysts ensuring simplified operations and reliable supply chain solutions for pharmaceutical applications
Breakthrough aqueous-phase C-N coupling technology enabling cost-effective production of complex pharmaceutical intermediates with enhanced supply chain reliability.
Patent CN114409515B introduces a mild metal-free hydrodefluorination method enabling high-purity gem-difluoroalkenes with enhanced scalability and cost reduction in pharmaceutical manufacturing.
Patent CN100463720C introduces a novel binaphthyl axis-containing chiral catalyst enabling high-yield asymmetric synthesis with enhanced supply chain reliability and significant cost reduction potential for pharma intermediates.
Patent CN107501153A introduces a cost-efficient method eliminating expensive reagents while enhancing supply chain reliability through scalable fluorinated intermediate production.
Novel phosphine ligands enable high-yield Markovnikov hydroboration with exceptional enantioselectivity while improving supply chain reliability for pharmaceutical intermediates.
Innovative cascade reaction for high-purity pyrrole derivatives with mild conditions and scalable production for pharmaceutical supply chains.
Patent CN110467579B introduces an iodine-catalyzed method for high-purity triazole compounds enabling simplified production and enhanced supply chain reliability for pharmaceutical intermediates.